Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries

Fig. 1

Samples used for technical validation of the 5-marker panel. Technical validation of the 5-marker panel was performed using Quantitative Multiplex-Methylation-Specific PCR (QM-MSP) on archival formalin-fixed paraffin-embedded (FFPE)-tissue and cervical smear and liquid-based cytology (LBC) samples. SCC—squamous cell carcinoma; CIN2/3—cervical intraepithelial neoplasia 2/3; CIN1—cervical intraepithelial neoplasia 1; HSIL—high-grade squamous intraepithelial lesion, LSIL—low-grade squamous intraepithelial lesion

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us